Garami, G.; Obajed Al-Ali, O.; Virga, I.; Gulyás, A.; Bedekovics, J.; Tornai, I.; Illés, Á.; Magyari, F.
Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. Curr. Oncol. 2025, 32, 63.
https://doi.org/10.3390/curroncol32020063
AMA Style
Garami G, Obajed Al-Ali O, Virga I, Gulyás A, Bedekovics J, Tornai I, Illés Á, Magyari F.
Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. Current Oncology. 2025; 32(2):63.
https://doi.org/10.3390/curroncol32020063
Chicago/Turabian Style
Garami, Gréta, Omar Obajed Al-Ali, István Virga, Anita Gulyás, Judit Bedekovics, István Tornai, Árpád Illés, and Ferenc Magyari.
2025. "Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation" Current Oncology 32, no. 2: 63.
https://doi.org/10.3390/curroncol32020063
APA Style
Garami, G., Obajed Al-Ali, O., Virga, I., Gulyás, A., Bedekovics, J., Tornai, I., Illés, Á., & Magyari, F.
(2025). Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. Current Oncology, 32(2), 63.
https://doi.org/10.3390/curroncol32020063
